The microbiome revolution

ESMO 2017 roundup with Dr Bishal Gyawali (1/2)

ESMO 2017 roundup with Dr Bishal Gyawali (2/2)

Initial results of inhibitor combination against breast and gynaecologic cancers

Patient empowerment and quality of life

LORELEI trial of letrozole and taselisib for ER positive breast cancer

Fertility-preserving procedures in BRCA mutation-positive breast cancer

Nivolumab and ipilimumab for metastatic kidney cancer

Biological insight in new drug combinations

Checkmate 238: Adjuvant checkpoint therapy after melanoma resection

The role of tumour marker testing in early diagnosis

The METRIC trial of trametinib, five years on